81
Views
0
CrossRef citations to date
0
Altmetric
Research Articles

Formulation and optimization of lipid- and Poloxamer-tagged niosomes for dermal delivery of terbinafine: preparation, evaluation, and in vitro antifungal activity

, , &
Pages 803-810 | Received 30 Apr 2023, Accepted 02 Sep 2023, Published online: 11 Sep 2023

References

  • Abbas P, Jaleh V, Abdolhossein RI. 2007. In-vitro study of polyoxyethylene alkyl ether niosomes for delivery of insulin. Int J Pharm. 328:130–141.
  • Abdelkader H, Alani A, Alany RG. 2014. Recent advances in non-ionic surfactant vesicles (niosomes): self-assembly, fabrication, characterisation, types, drug delivery applications and limitations. Drug Deliv. 21(2):87–100. doi: 10.3109/10717544.2013.838077.
  • Abdelkader H, Ismail S, Kamal A, Alany RG. 2011. Design and evaluation of controlled release niosomes and discomes for naltrexone hydrochloride ocular delivery. J Pharm Sci. 100(5):1833–1846. doi: 10.1002/jps.22422.
  • Abdelkader H, Kamal A, Ismail S, Alany RG. 2010. Preparation of niosomes as an ocular delivery system for naltrexone hydrochloride. Physicochem Charact Pharm. 65:811–817.
  • Aburahma M, Badr-Eldin S. 2014. Compritol 888 ATO: a multifunctional lipid excipient in drug delivery systems and nanopharmaceuticals. Expert Opin Drug Deliv. 11(12):1865–1883. doi: 10.1517/17425247.2014.935335.
  • Ahmed SH, Amin MA, Saafan AE, El-Gendy AO, Ul Islam M. 2013. Measuring susceptibility of Candida albicans biofilms towards antifungal agents. Der Pharm Lett. 5:376–383.
  • Aparajay P, Dev A. 2022. Functionalized niosomes as a smart delivery device in cancer and fungal infection. Eur J Pharm Sci. 168:106052. doi: 10.1016/j.ejps.2021.106052.
  • Apsara S, Opatha T, Titapiwatanakun V, Chutoprapat R. 2020. Transfersomes: a promising nanoencapsulation technique for transdermal drug delivery. Pharmaceutics. 12(9):855. doi: 10.3390/pharmaceutics12090855.
  • Azeem A, Ahmad FJ, Khan ZI, Talegaonkar S. 2008. Nonionic surfactant vesicles as a carrier for transdermal delivery of frusemide. J Dispers Sci Technol. 29(5):723–730. doi: 10.1080/01932690701751801.
  • Bhardwaj P, Tripathi P, Gupta R, Pandey S. 2020. Niosomes: a review on niosomal research in the last decade. J Drug Deliv Sci Technol. 56:101581. doi: 10.1016/j.jddst.2020.101581.
  • Chauhan M, Sahoo P, Rawat A, Singh A, Bamrara A, Sharma D. 2015. Bilosomes: a novel approach to meet the challenges in oral immunization. Recent Pat Drug Deliv Formul. 9:201–212.
  • El-Gendy AO, Essam TM, Amin MA, Ahmed SH, Nes IF. 2012. Clinical screening for bacteriocinogenic Enterococcus faecalis isolated from intensive care unit inpatient in Egypt. J Microb Biochem Technol. 4(7):161–167. doi: 10.4172/1948-5948.1000089.
  • El-Houssieny BM, Hamouda HM. 2010. Formulation and evaluation of clotrimazole from Pluronic F127 gels. Drug Discov Ther. 4:33–43.
  • Garg A, Sharma G, Goyal AK, Ghosh G, Chandra S, Rath G. 2020. Recent advances in topical carriers of anti-fungal agents. Heliyon. 6(8):e04663. doi: 10.1016/j.heliyon.2020.e04663.
  • Garg N, Aeron A. 2016. Laboratory manual of microbiology. Microbes in action. Bombay, India: Nova Science Publishers; p. 55–80.
  • Gupta M, Vaidya B, Mishra N, Vyas SP. 2011. Effect of surfactants on the characteristics of fluconazole niosomes for enhanced cutaneous delivery. Artif Cells Blood Substit Immobil Biotechnol. 39(6):376–384. doi: 10.3109/10731199.2011.611476.
  • Hajare A, Dol H, Patil K. 2021. Design and development of terbinafine hydrochloride ethosomal gel for enhancement of transdermal delivery: in vitro, in vivo, molecular docking, and stability study. J Drug Deliv Sci Technol. 61:102280. doi: 10.1016/j.jddst.2020.102280.
  • Hassan S, Khalid I, Hussain L, Barkat K, Khan I. 2022. Development and evaluation of pH-responsive Pluronic F 127 co-poly-(acrylic acid) biodegradable nanogels for topical delivery of terbinafine HCl. Dose Response. 20(2):15593258221095977. doi: 10.1177/15593258221095977.
  • Jain N, Verma A, Jain N. 2020. Formulation and investigation of pilocarpine hydrochloride niosomal gels for the treatment of glaucoma: intraocular pressure measurement in white albino rabbits. Drug Deliv. 27(1):888–899. doi: 10.1080/10717544.2020.1775726.
  • Karimkhani C, Dellavalle RP, Coffeng LE, Flohr C, Hay RJ, Langan SM, Nsoesie EO, Ferrari AJ, Erskine HE, Silverberg JI, et al. 2017. Global skin disease morbidity and mortality: an update of the global burden of disease study 2013. JAMA Dermatol. 153(5):406–412. doi: 10.1001/jamadermatol.2016.5538.
  • Lengert EV, Talnikova EE, Tuchin VV, Svenskaya Y. 2020. Prospective nanotechnology-based strategies for enhanced intra- and transdermal delivery of antifungal drugs. Skin Pharmacol Physiol. 33(5):261–269. doi: 10.1159/000511038.
  • Ma Y, Chen X, Guan S. 2015. Terbinafine: novel formulation that potentiate antifungal activities. Drugs Today. 51:197–208.
  • Muzzalupo R, Tavano L. 2015. Niosomal drug delivery for transdermal targeting: recent advances. Res Rep Transderm Drug Deliv. 4:23–33. doi: 10.2147/RRTD.S64773.
  • Quartier J, Lapteva M, Boulaguiem Y, Guerrier S, Kalia Y. 2023. Influence of molecular structure and physicochemical properties of immunosuppressive drugs on micelle formulation characteristics and cutaneous delivery. Pharmaceutics. 15(4):1278. doi: 10.3390/pharmaceutics15041278.
  • Rosen T, Gold LFS. 2016. Antifungal drugs for onychomycosis: efficacy, safety, and mechanisms of action. Semin Cutan Med Surg. 35:S51–S55.
  • Schreier H, Bouwstra J. 1994. Liposomes and niosomes as topical drug carriers: dermal and transdermal drug delivery. J Control Release. 30(1):1–15. doi: 10.1016/0168-3659(94)90039-6.
  • Shi H, Xie Y. 2017. Solubility and thermodynamics of terbinafine hydrochloride in different neat and binary solvents: measurement, correlation and molecular interactions. J Mol Liq. 243:293–301. doi: 10.1016/j.molliq.2017.08.052.
  • Tarek N, Hassan HM, AbdelGhani SM, Radwan IA, Hammouda O, El-Gendy A. 2014. Comparative chemical and antimicrobial study of nine essential oils obtained from medicinal plants growing in Egypt. Beni-Suef Univ J Basic Appl Sci. 3(2):149–156. doi: 10.1016/j.bjbas.2014.05.009.
  • Urban K, Chu S, Scheufele C, Giesey RL, Mehrmal S, Uppal P, Delost GR. 2021. The global, regional, and national burden of fungal skin diseases in 195 countries and territories: a cross-sectional analysis from the Global Burden of Disease Study 2017. JAAD Int. 2:22–27. doi: 10.1016/j.jdin.2020.10.003.
  • Zhang L, Li X, Zhu S, Zhang T, Maimaiti A, Ding M, Sh S. 2020. Dermal targeting delivery of terbinafine hydrochloride using novel multi-ethosomes: a new approach to fungal infection treatment. Coatings. 10(4):304. doi: 10.3390/coatings10040304.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.